Citicoline & Citicoline Sodium: The Definitive Technical & Commercial Guide for Pharmaceutical Manufacturers, Compounding Pharmacists & API Importers
Citicoline, or CDP-Choline, is a powerhouse nootropic and neuroprotective agent gaining traction in clinical and wellness circles.
From boosting cognitive performance to aiding stroke recovery, this compound is a staple in compounding pharmacies and a sought-after API for pharmaceutical distributors.
But what makes citicoline API stand out in the crowded world of brain health supplements?
This comprehensive guide will examine citicoline’s mechanism of action, benefits, and side effects, and how it compares to alternatives such as Alpha-GPCC and phosphatidylserine.
Whether you’re a compounding pharmacist formulating custom therapies or an API importer sourcing high-quality raw materials, this post equips you with the knowledge to rank citicoline-related keywords and meet your audience’s needs.
What is Citicoline and Citicoline Sodium?
Citicoline—known scientifically as cytidine-5′-diphosphocholine (CDP-Choline)—is an endogenous mononucleotide compound composed of ribose, cytosine, pyrophosphate, and choline.
First identified by Kennedy and colleagues in 1955 and synthesized in 1956, citicoline has since been studied extensively across Europe, Japan, and the United States as both a pharmaceutical agent and a dietary supplement ingredient.
As an essential intermediate in the biosynthesis of phosphatidylcholine—the major phospholipid in eukaryotic cell membranes—citicoline plays a fundamental role in maintaining cellular membrane integrity and function.
It also serves as a choline donor in the biosynthesis of the neurotransmitter acetylcholine, making it critically important for cognitive function and neurological health.
Citicoline vs. Citicoline Sodium: Understanding the Distinction
There are two primary forms of citicoline available commercially:
Citicoline Free-Base: This form has been available as a dietary supplement in the United States for three decades. It is typically used in nutraceutical applications and over-the-counter cognitive health products.
Citicoline Sodium: This is the sodium salt form of citicoline, primarily used in other countries as a pharmaceutical drug or para-drug for the treatment of neurological disorders. It is the preferred form for injectable formulations and is widely used in regulated pharmaceutical markets.
The CAS number for Citicoline Sodium is 33818-15-4. From a manufacturing perspective, citicoline sodium offers distinct advantages in terms of stability and solubility, making it the preferred API form for pharmaceutical formulation development.
For pharmaceutical manufacturers and compounding pharmacists, understanding this distinction is critical when sourcing APIs and developing formulations. The sodium salt form is typically specified in pharmacopeial monographs and regulatory submissions.
Chemical and Physical Properties
Citicoline sodium is a water-soluble, highly bioavailable compound. Its molecular structure comprises:
Ribose: A five-carbon sugar that forms the backbone
Cytosine: A pyrimidine nucleobase
Pyrophosphate: The diphosphate linkage
Choline: The essential nutrient moiety
The compound is stable under standard manufacturing and storage conditions when properly handled. Its water solubility makes it amenable to both oral and parenteral formulation development.
What is Citicoline and Citicoline Sodium Used For?
Citicoline has been investigated for a remarkably broad spectrum of clinical indications, ranging from acute neurological emergencies to chronic neurodegenerative conditions.
FDA-Approved and Regulatory Status
Citicoline has not received FDA approval as a drug in the United States for any specific indication.
However, it is widely available as a dietary supplement. In many other countries—including Japan, various European nations, and countries throughout Asia and Latin America—citicoline is approved as a pharmaceutical product for the treatment of neurological disorders.
Primary Clinical Applications
Cerebrovascular Disorders and Stroke
Citicoline has been extensively studied in the context of acute ischemic stroke. Clinical trials have evaluated oral citicoline at doses ranging from 500 mg to 2,000 mg per day.
The ICTUS trial, a large international randomized controlled study, administered citicoline at 1,000 mg every 12 hours intravenously during the first three days and orally thereafter for a total of six weeks.
Traumatic Brain Injury (TBI)
Citicoline is indicated for the treatment of traumatic brain injury and its neurological sequelae. In rodent models of TBI, citicoline has demonstrated neuroprotective effects by activating microglia and reducing neuronal apoptosis.
Cognitive Impairment and Dementia
Citicoline has shown consistent improvement in cognitive function in patients with mild cognitive impairment (MCI), particularly of vascular origin.
It provides beneficial effects on vascular, Alzheimer’s, and mixed dementias, as well as stroke sequelae, intracerebral hemorrhages, traumatic brain injuries, and neurodegenerative diseases.
Parkinson’s Disease
Citicoline has been evaluated for its potential benefits in Parkinson’s disease.
Glaucoma and Visual Pathway Disorders
Citicoline has demonstrated neuroprotective, neurorestorative, and neuroregenerative effects in retinal ganglion cells, providing a strong rationale for its use in visual pathway disorders including glaucoma and amblyopia.
Substance Abuse and Psychiatric Disorders
Citicoline has been investigated for the treatment of conditions including mania, cocaine abuse, and bipolar disorder.
Ophthalmologic Applications
Beyond glaucoma, citicoline has been studied for amblyopia and ischemic optic neuropathy.
Market Context
The global citicoline market was valued at approximately $2.1 billion in 2025 and is projected to reach $4.0 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7.4%.
This growth is driven by surging demand for neuroprotective compounds across pharmaceutical and nutraceutical applications, presenting significant opportunities for API manufacturers, compounders, and importers.
How Does Citicoline Work? (Mechanism of Action)
The mechanism of action of citicoline is multifaceted, involving both direct and indirect neuroprotective pathways.
Understanding these mechanisms is essential for pharmaceutical professionals developing formulations and clinicians optimizing therapeutic protocols.
Phosphatidylcholine Synthesis (The Kennedy Cycle)
Citicoline serves as an essential intermediate in the biosynthesis of phosphatidylcholine, the major phospholipid of eukaryotic cell membranes.
When taken orally, citicoline is hydrolyzed in the intestinal tract and in the circulation to form choline and cytidine—the nucleoside of cytosine.
Once these components cross the blood-brain barrier, they are efficiently utilized in the Kennedy cycle to regenerate citicoline and synthesize phospholipids.
The rate-limiting enzyme in this pathway is CTP-phosphocholine cytidylyltransferase.
Neurotransmitter Support
Citicoline provides the brain with a source of choline, which is utilized for the synthesis of acetylcholine—a key neurotransmitter involved in memory, attention, and cognitive function.
Additionally, citicoline appears to increase the availability of the neurotransmitters norepinephrine and dopamine.
Neuroprotective Effects
Citicoline exerts neuroprotective effects through multiple mechanisms:
Membrane Stabilization: By supporting phosphatidylcholine synthesis, citicoline helps maintain cell membrane integrity and function. This is particularly important during ischemic or traumatic injury, when membrane phospholipids are degraded.
Antioxidant Activity: Studies suggest that citicoline may reduce oxidative stress and inflammation in neuronal tissues. Antioxidant effects have been demonstrated in several models, including brain, renal, and hepatic injury.
Anti-Inflammatory Effects: Citicoline has demonstrated anti-inflammatory potential across a spectrum of neurological conditions. In Alzheimer’s disease models, citicoline administration significantly decreased levels of pro-inflammatory cytokines including MIP-1α, TNFα, IL-1β, and MCP-1.
Mitochondrial Modulation: Citicoline is recognized for its capacity to modulate mitochondrial homeostasis, contributing to its neuroprotective properties.
Apoptosis Inhibition: Citicoline preserves the neuronal energetic reserve and inhibits apoptosis.
Glutamate Regulation: Citicoline appears to decrease glutamate levels in the brain and increase adenosine triphosphate (ATP), offering protection against ischemic neurotoxicity.
Cerebral Blood Flow and Metabolism
Citicoline has been shown to increase blood flow and oxygen consumption in the brain. It also increases glucose metabolism and cerebral blood flow.
Clinical Implications of the Mechanism
The multimodal mechanism of citicoline explains its broad therapeutic potential across diverse neurological conditions.
Unlike single-target agents, citicoline addresses multiple pathways involved in neuronal health and recovery—membrane integrity, neurotransmitter synthesis, oxidative stress, inflammation, and energy metabolism.
What Are the Benefits of Citicoline?
For pharmaceutical manufacturers, compounding pharmacists, and clinicians, citicoline offers several distinct therapeutic and commercial advantages:
Clinical Benefits
Neuroprotection Across Multiple Conditions: Citicoline has demonstrated protective effects in cerebral ischemia, traumatic brain injury, and memory disorders. It has shown consistent improvement in cognitive function in patients with MCI, especially of vascular origin.
Cognitive Enhancement: Citicoline has been shown to improve memory, attention, and cognitive function in various forms of cognitive impairment, including Alzheimer’s disease, mixed dementia, post-stroke dementia, and MCI.
Stroke Recovery: While the evidence base has evolved, pooled analysis of randomized clinical trials showed that oral citicoline at doses between 500 mg and 2,000 mg per day was associated with an odds ratio of 1.33 (95% CI: 1.10–1.62) in complete functional recovery.
Visual Function Support: Citicoline has demonstrated benefits in glaucoma and other visual pathway disorders.
Safety Profile Benefits
Excellent Tolerability: Citicoline was well tolerated in clinical trials. Adverse effects are generally mild and transient.
Low Toxicity: Administering choline with cytidine in the form of citicoline lowers the toxicity index by twentyfold compared to choline alone.
Minimal Drug Interactions: None are well documented.
Safe for Long-Term Use: Long-term treatment with citicoline has been demonstrated to be well-tolerated and has not been associated with severe adverse events.
Commercial Benefits
Growing Market: The global citicoline market is projected to reach $4.0 billion by 2034.
Multiple Delivery Platforms: Citicoline can be formulated as oral tablets, oral solutions, injectables, and topical preparations.
Dual Pharmaceutical and Nutraceutical Applications: Citicoline serves both regulated pharmaceutical markets and the rapidly growing dietary supplement sector.
Established Supply Chain: Multiple GMP-certified API manufacturers globally supply citicoline sodium.
What Are Citicoline Side Effects?
Understanding the adverse effect profile of citicoline is essential for pharmaceutical manufacturers developing patient information materials, compounding pharmacists counseling patients, and clinicians making prescribing decisions.
Common Side Effects
Citicoline is generally well tolerated in clinical trials. The most frequently reported adverse effects include:
Gastrointestinal Disturbances: Nausea, vomiting, anorexia (loss of appetite), stomach pain, epigastric distress, and diarrhea
Nervous System Effects: Headache, dizziness, and in some cases, convulsions
Psychiatric Effects: Insomnia, excitation, restlessness, and anxiety
Cardiovascular Effects: Transient hypotension (temporary blood pressure decrease), bradycardia (slow heart rate), and tachycardia (rapid heart rate)
Injection Site Reactions (for parenteral formulations): Rash, feeling of warmth
Other Effects: Fatigue, malaise, transient diplopia (double vision), and dyspnea (shortness of breath)
Rare but Serious Adverse Events
Allergic Reactions: Occasional reports of fever, malaise, and allergic reactions; severe cases of anaphylactic shock have been reported
Liver Function Abnormalities: Abnormal liver function tests have been reported
Cardio-Respiratory Arrest: Rare cases reported
Safety in Special Populations
Pregnancy and Lactation: Information regarding safety and efficacy in pregnancy and lactation is lacking at dosages above those usually consumed nutritionally. Caution is advised.
Pediatric Patients: While citicoline and phosphatidylserine are generally well-tolerated, a case report highlighted the potential for serious side effects in sensitive pediatric patients, particularly when used concomitantly with stimulants.
Intracranial Bleeding: Avoid giving high-dose citicoline (>500 mg) in intracranial bleeding.
Adverse Event Frequency
In one observational study, 37 side effects were observed in 31 patients (0.73%). The most frequent findings were nervous system-related symptoms (8 of 37, 21.62%), followed by gastrointestinal symptoms (5 of 37, 13.5%).
Citicoline Dosage and Administration
Dosage regimens for citicoline vary significantly depending on the indication, formulation type, route of administration, and severity of the condition.
Oral Administration
General Adult Dosage: The usual daily therapeutic dosage of citicoline is 500–2,000 mg. Oral dosages of 250 to 2,000 mg daily have been evaluated in adolescents and adults in clinical trials.
Tablet Form: 500 mg, one to two times daily, or 1,000 mg once daily.
Oral Solution: 100–200 mg two to three times daily; or 500–2,000 mg daily, depending on the severity of symptoms. The solution can be administered directly or dissolved in half a glass (120 mL) of water.
Lower Doses: Doses of 100 mg twice daily have been used in short-term trials (6 weeks) with combination therapy in patients with major depressive disorder.
Parenteral Administration (Intravenous and Intramuscular)
Intravenous Infusion: 250–500 mg daily, diluted in 5% or 10% glucose solution and infused slowly, typically in 5- to 10-day courses.
Intravenous Injection: 100–200 mg per dose.
Intramuscular Injection: 100–300 mg daily, divided into one or two injections.
Severe Conditions: 1,000–2,000 mg daily via intramuscular injection, slow intravenous injection (3–5 minutes), or intravenous infusion (infusion rate: 40–60 drops per minute).
ICTUS Trial Protocol: 1,000 mg every 12 hours intravenously during the first 3 days and orally thereafter for a total of 6 weeks (2 × 500 mg oral tablets given every 12 hours).
Administration Guidelines
Citicoline may be taken with or without food
For injectable formulations, slow administration is recommended
In cases of persistent intracranial hemorrhage, it is recommended to administer citicoline very slowly at 30 drops per minute
Dosage Individualization
Dosage should be individualized according to the severity of the disease. Dosage recommendations may vary among countries or individual products.
How Long Does Citicoline Take to Work?
The onset of action of citicoline depends on several factors, including the route of administration, the condition being treated, and individual patient characteristics.
Pharmacokinetic Profile
Absorption: Citicoline is almost completely absorbed following oral administration. It is well absorbed via intramuscular and intravenous routes as well.
Bioavailability: Citicoline has an absolute bioavailability of approximately 90–99%. It is a water-soluble compound with greater than 90% bioavailability.
Time to Peak Plasma Concentration: Following oral administration, citicoline exhibits a biphasic absorption pattern, with peak plasma concentrations occurring at approximately 1 hour and 24 hours.
Distribution: Citicoline is widely distributed in brain structures and crosses the blood-brain barrier.
Clinical Onset
Acute Conditions (Stroke, TBI): In acute neurological conditions, intravenous administration may produce more rapid effects. The ICTUS trial protocol involved intravenous administration during the first three days.
Chronic Conditions (Cognitive Impairment, Dementia): For chronic conditions, therapeutic effects typically develop over weeks to months of consistent dosing. Clinical trials have evaluated treatment durations ranging from 6 weeks to several months.
Patient Expectations: While some patients may notice improvements in cognitive function within days to weeks, the full therapeutic benefits of citicoline in chronic neurodegenerative conditions may require sustained treatment over extended periods.
How Long Does Citicoline Stay in Your System?
The residence time of citicoline in the body is determined by its pharmacokinetic properties, which are well-characterized and relevant to pharmaceutical manufacturers developing extended-release or sustained-release formulations.
Metabolism
Citicoline is metabolized in the liver and gut wall via hydrolysis to form choline and cytidine. The liver can synthesize lecithin from choline and resynthesize citicoline from cytidine and choline.
Elimination Half-Life
Urinary Elimination Half-Life: 71 hours
Respiratory CO₂ Elimination Half-Life: 56 hours
Excretion
Citicoline is primarily eliminated via:
Respiratory CO₂: The major route of elimination
Urine: Significant elimination via the renal route
Feces: Less than 1% excreted in the feces
Implications for Dosing
The long elimination half-life (71 hours via urine) supports once-daily or twice-daily dosing regimens.
The prolonged residence time also means that steady-state concentrations are achieved after several days of consistent dosing.
Citicoline Precautions and Drug Interactions
A comprehensive understanding of precautions and drug interactions is essential for pharmaceutical manufacturers developing product labeling and for clinicians prescribing the medication.
Contraindications
Hypersensitivity to citicoline or any excipient in the formulation
Hypertonia of the parasympathetic nervous system
Parasympathetic hypertonia
Special Precautions
Intracranial Hemorrhage: Avoid giving high-dose citicoline (>500 mg) in intracranial bleeding. In cases of persistent intracranial hemorrhage, administer very slowly at 30 drops per minute.
Acute, Severe, and Progressive Disturbances: Use caution in patients with acute, severe, or progressive disturbances.
Pregnancy and Lactation: Information regarding safety and efficacy in pregnancy and lactation is lacking at dosages above those usually consumed nutritionally. Caution is advised.
Pediatric Use: Caution advised.
Fructose Intolerance: Oral solutions may contain fructose and should be avoided in patients with fructose intolerance.
Asthma: Oral solutions may cause asthma in patients with hypersensitivity to acetylsalicylic acid (ASA).
Drug Interactions
Potentiation of Levodopa: Citicoline potentiates the effects of levodopa. Dose adjustments of levodopa may be necessary.
Meclofenoxate/Centrophenoxine: Citicoline should not be co-administered with meclofenoxate-containing medications. Do not administer with centrophenoxine.
No Well-Documented Interactions: Aside from the above, no well-documented drug interactions have been identified.
Pregnancy and Lactation Considerations
Given the limited safety data at supranutritional doses, citicoline should be used during pregnancy and lactation only when the potential benefits justify the potential risks to the fetus or infant.
Citicoline vs Alpha GPC
For pharmaceutical manufacturers and compounding pharmacists developing cholinergic products, understanding the comparative profiles of citicoline and Alpha GPC (L-alpha-glycerylphosphorylcholine) is essential for product positioning and formulation decisions.
Structural and Mechanistic Differences
Alpha GPC: A choline-containing phospholipid that releases free choline upon metabolism. Its mode of action involves releasing free choline, which is then used for acetylcholine and phosphatidylcholine biosynthesis in the brain.
Citicoline: Provides both choline and cytidine, which are efficiently used in the Kennedy cycle to generate phospholipids. Studies in neuronal cell lines showed that cytidine administration increased the incorporation of choline into membrane phosphatidylcholine.
Comparative Efficacy
Alpha GPC is more effective than citicoline in improving somatic functioning, as measured by the SCAG (Sandoz Clinical Assessment-Geriatric) scale.
Citicoline may provide a more balanced improvement in focus, mental clarity, and attention span, likely due to its dual role in choline and uridine synthesis.
Clinical Positioning
Alpha GPC is often framed as fast-acting and neurologically potent, ideal for acute mental and physical performance. It is popular in athletic and performance-focused nootropic stacks.
Citicoline is positioned more for sustained cognitive repair and phospholipid regeneration. It is often favored for long-term cognitive support.
Formulation Considerations
Alpha GPC: Typically provides a higher free choline yield per gram, meaning less material may be needed to deliver a similar choline contribution.
Citicoline: Often smoother in effect; gram-for-gram typically delivers more usable choline yield compared with Alpha GPC.
Choosing Between the Two
The choice between citicoline and Alpha GPC depends on the intended application:
Acute cognitive performance: Alpha GPC may be preferred
Long-term neuroprotection and cognitive repair: Citicoline may be preferred
Combination therapy: Both can be used synergistically (see below)
Citicoline vs. Phosphatidylserine
Phosphatidylserine (PS) and citicoline are both popular cognitive health ingredients, but they have distinct mechanisms and formulation characteristics.
Mechanism Differences
Citicoline: Provides choline and cytidine for phosphatidylcholine synthesis and neurotransmitter support. It is a precursor to membrane phospholipids.
Phosphatidylserine: Is itself a membrane phospholipid that is directly incorporated into cell membranes. It plays a role in cell signaling and neurotransmitter release.
Comparative Positioning
Phosphatidylserine currently carries more “brain health” authority with B2B buyers and is seen as the established gold standard for memory.
Citicoline Sodium is far more practical to stabilize—it is water-soluble, robust, and requires no special technology.
Formulation Considerations
Citicoline Sodium: Water-soluble, easy to formulate, stable under standard conditions.
Phosphatidylserine: Requires extra processing like encapsulation to mix properly and avoid an oily feel. Not automatically a better option due to formulation challenges.
Citicoline Sodium tends to pull in moisture and cause texture issues like sweating or grittiness unless handled under very dry conditions.
Clinical Evidence
Phosphatidylcholine (PC) and citicoline are thought to promote synthesis and transmission of neurotransmitters important to memory. However, PC has not proven effective for improving memory in patients with probable Alzheimer’s disease.
Choline vs Citicoline
Understanding the distinction between citicoline and choline is fundamental for pharmaceutical professionals developing cholinergic products.
Chemical Distinction
Choline: An essential nutrient and component of the diet, produced in the brain in small amounts.
Classified with the B-vitamin complex, it plays several essential roles in human physiology, including enhancing structural integrity and signaling in cell membranes, supporting acetylcholine synthesis, and synthesizing betaine.
Citicoline: An endogenous mononucleotide composed of ribose, cytosine, pyrophosphate, and choline. When taken orally, citicoline is hydrolyzed to form choline and cytidine.
Comparative Advantages of Citicoline
Lower Toxicity: Administering choline with cytidine, in the form of citicoline, lowers the toxicity index by twentyfold.
Reduced Cholinergic Effects: Choline shows a remarkable cholinergic action, while CDP-choline—both orally and intravenously—does not cause any cholinergic intoxication.
Superior for Cerebral Ischemia: Citicoline administration is significantly different from choline administration in cases of cerebral ischemia caused by stroke.
Reduced TMAO Formation: Compared to the choline moiety in other dietary sources such as phosphatidylcholine, choline in citicoline is less prone to conversion to trimethylamine (TMA) and its putative atherogenic N-oxide (TMAO).
Clinical Implications
While choline is an essential nutrient that must be obtained through the diet, citicoline offers superior targeted delivery to the brain and a more favorable safety profile.
For pharmaceutical and nutraceutical applications, citicoline is generally the preferred form for cognitive health products.
Can You Take Alpha GPC and Citicoline Together?
For pharmaceutical manufacturers and compounding pharmacists developing combination products, understanding the synergistic potential of Alpha GPC and citicoline is essential.
Synergistic Potential
Among nootropic users, combining Alpha GPC and Citicoline can produce a nuanced synergistic effect. When stacked, some users report enhanced multitasking ability, greater fluidity of thought, and reduced mental fatigue.
Mechanism of Synergy
When Alpha GPC is paired with Citicoline, the result is a powerful combination for cognitive enhancement. Taking Alpha GPC and citicoline together helps amplify acetylcholine levels, further promoting cognitive functions like memory, focus, and learning.
Citicoline works synergistically with Alpha GPC to drive phosphatidylcholine synthesis.
Individual Response
Individual response often dictates whether this stack feels complementary or redundant. Some users find that one source suffices—often preferring citicoline for its smoother, longer-tail benefits or Alpha GPC for more immediate cognitive drive.
Formulation Recommendations
For combination products:
Dose balancing is critical for optimal synergy
Consider the intended use: acute performance vs. long-term support
Monitor for overstimulation in sensitive individuals
Compounding Guidelines for Citicoline
For compounding pharmacists, preparing citicoline-containing formulations requires adherence to rigorous quality standards, precise measurement, and appropriate excipient selection.
Regulatory Framework
Compounding of citicoline should comply with:
USP <795> (Pharmaceutical Compounding—Nonsterile Preparations)
USP <797> (Pharmaceutical Compounding—Sterile Preparations, for injectable formulations)
State Board of Pharmacy regulations
Applicable FDA guidance on compounding
API Quality and Sourcing
Source citicoline sodium API from GMP-certified suppliers with appropriate documentation
Verify certificate of analysis (COA) for each batch, including:
Assay (potency): Typically ≥ 99% purity
Impurity profile
Residual solvents
Microbial limits
Ensure API is USP/Ph.Eur./BP grade as appropriate for the intended use
Formulation Development
Oral Capsules:
Typical excipients: Microcrystalline cellulose, magnesium stearate, silicon dioxide
Target fill weight: Based on desired potency (typically 250 mg, 500 mg, or 1,000 mg per capsule)
Content uniformity: Critical parameter; ensure thorough mixing and proper geometric dilution
Oral Tablets:
Process: Wet granulation or direct compression
Excipients: Microcrystalline cellulose, lactose, croscarmellose sodium, povidone, magnesium stearate
Coating: Film coating for taste masking and stability
Oral Solutions:
Solubility: Citicoline sodium is water-soluble
Preservatives: Consider antimicrobial preservation for multi-dose preparations
Flavoring: For patient compliance
Parenteral Formulations:
Sterility: Must be prepared under USP <797> conditions
Vehicle: 5% or 10% glucose solution
Preservatives: Typically preservative-free for single-use vials
Filtration: Sterile filtration (0.22 micron) required
Quality Control Testing
Assay: HPLC-UV method for potency verification
Content uniformity: USP <905> requirements for solid dosage forms
Dissolution testing: USP apparatus I or II, appropriate medium
Sterility testing: For parenteral formulations
Endotoxin testing: For parenteral formulations
Stability studies: Real-time and accelerated stability per ICH guidelines
Stability Considerations
Storage: Store below 30°C
Protection: Protect from excessive heat, light, and moisture
Shelf-life: Typically ≤ 6 months for compounded non-sterile preparations (based on stability data)
Labeling Considerations
Active ingredient: Citicoline or Citicoline Sodium, with strength clearly stated
Indication: Specific to compounded formulation
Dosage instructions: Clear, patient-friendly language
Expiration date: Based on stability data
Storage conditions: As determined by stability studies
Lot number and beyond-use date
Documentation
Maintain thorough compounding records, including:
Batch numbers of all ingredients
Expiration dates
Quality control results
Compounding procedure and equipment used
Sourcing Tips for Citicoline and Citicoline Sodium API
For pharmaceutical manufacturers, compounding pharmacies producing large volumes, and API importers, strategic sourcing of citicoline sodium API is critical for ensuring product quality, regulatory compliance, and supply chain resilience.
Regulatory and Quality Considerations
When selecting a citicoline sodium API supplier, the following factors should be rigorously evaluated:
GMP Certification: Ensure facilities meet current Good Manufacturing Practice standards. CTX Lifesciences, for example, has accreditation from US-FDA, EDQM, EMA, ANVISA, KFDA, and Health Canada.
DMF Availability: Drug Master File availability facilitates regulatory submissions.
Analytical Rigor: Batch-to-batch consistency, purity (typically ≥ 99%), and potency verification.
Regulatory Approvals: Look for suppliers with established regulatory track records.
Supply Chain Reliability: Proven track record and capacity to meet demand.
Global Footprint: Suppliers exporting to multiple regions demonstrate quality and reliability.
Sourcing Best Practices
Conduct Thorough Supplier Audits: On-site audits where feasible; review quality systems, manufacturing processes, and documentation.
Request Comprehensive Documentation: COAs, stability data, impurity profiles, DMFs.
Establish Quality Agreements: Clearly define specifications, testing requirements, and change control procedures.
Diversify Supply Sources: Maintain relationships with multiple suppliers to mitigate geopolitical and supply chain risks.
Verify Regulatory Status: Ensure the supplier’s API is approved for use in your target markets.
Quality Specifications to Request
Assay: Typically 98.0%–102.0% on dried basis; USP grade ≥ 99%
Impurity profile: Individual impurities as per pharmacopeial limits
Particle size: As specified for your formulation process
Residual solvents: Per ICH Q3C guidelines
Microbial limits: USP <61> and <62> compliance
Appearance: White to off-white powder
Cost Considerations
Indian suppliers: Competitive pricing, strong quality systems, extensive GMP compliance
Chinese suppliers: Cost-competitive, expanding capabilities, rigorous quality monitoring essential
Quality-to-price ratio: Balance cost with regulatory requirements for your target market
Market Intelligence
The global citicoline market is projected to grow from approximately $2.1 billion in 2025 to $4.0 billion by 2034. Understanding these trends informs strategic procurement decisions and timing.
How Much Does Bulk Citicoline API Cost?
If you are looking for Pharma-Grade Citicoline API with GMP to do compounding or manufacture medicines, or you only need it for your scientific research, please find our cost details below:
For 1 kilo, our EXW price is around 980 USD per kilo.
For 10 kilos, our FOB cost is about 900 USD/kg.
If you can order 25 kilograms or more, our price is about 650 USD per kg.
For small business owners, such as compounding pharmacies, our price for 100 grams is 650 USD, including courier shipping costs.
For other quantities, please get in touch with us directly for updated prices.
Other FAQs About Citicoline
Q: Is citicoline safe for long-term use?
A: Yes, it is.
Studies confirm safety for up to 12 months at 2,000 mg/day.
Q: Can citicoline reverse dementia?
A: While it can’t cure dementia, it slows progression and improves quality of life.
Q: Does citicoline interact with medications?
A: No significant interactions were reported, but consult a doctor if using anticoagulants.
Conclusion
Citicoline and Citicoline Sodium represent one of the most thoroughly characterized and clinically validated neuroprotective compounds in contemporary pharmaceutical and nutraceutical practice. From its fundamental role as an essential intermediate in phosphatidylcholine biosynthesis to its demonstrated efficacy across a broad spectrum of neurological conditions—including stroke, traumatic brain injury, cognitive impairment, dementia, Parkinson’s disease, and glaucoma—this endogenous nucleotide has demonstrated remarkable versatility, safety, and therapeutic potential across decades of clinical investigation.
For pharmaceutical manufacturers, citicoline offers a well-established scientific foundation, extensive clinical data, and a growing global market projected to reach $4.0 billion by 2034. The availability of multiple delivery platforms—oral tablets, oral solutions, injectables, and emerging topical applications—provides opportunities for product portfolio diversification and market expansion. The compound’s excellent safety profile, minimal drug interactions, and low toxicity make it an attractive candidate for both acute and chronic indications.
For compounding pharmacists, citicoline presents opportunities for individualized patient care, particularly when commercial products are unavailable, require dose adjustments, or when specific formulation modifications are needed. Adherence to rigorous compounding standards, appropriate excipient selection, and thorough quality control are essential for ensuring patient safety and therapeutic efficacy.
For API importers and procurement professionals, the citicoline sodium API market offers multiple sourcing options across India, China, and other manufacturing hubs. Strategic supplier selection—balancing cost, quality, regulatory compliance, and supply chain reliability—is paramount for maintaining product quality and market competitiveness. With the global citicoline market experiencing robust growth, informed procurement strategies will be increasingly valuable.
As the pharmaceutical and nutraceutical industries continue to evolve, with increasing emphasis on neuroprotection, cognitive health, and evidence-based supplementation, citicoline’s established position and proven track record make it a reliable and strategic choice for manufacturers, compounders, and importers alike. Whether developing new formulations, optimizing existing products, or securing reliable API supply, a comprehensive understanding of citicoline’s pharmacology, clinical applications, and commercial landscape is essential for success in the competitive neuroprotective therapeutics market.
Disclaimer:
This content is for informational purposes only and is intended for business-to-business communication within the pharmaceutical industry. It is not intended as medical advice. The manufacture, import, and use of API must comply with all applicable laws and regulations in the relevant country or region.
This blog post is informational only and does not constitute medical advice.
Always consult a healthcare professional before starting any new medication or treatment.
Can/should I stack Citicoline GPC, Citicoline Sodium and Citicoline CDP? The effects of each one address various issues for me.
We are not medical practioners, we will approve your comment and let more pharmacists to share their ideas